Cargando…
Risk factors for de novo hepatitis B during solid cancer treatment
BACKGROUND: Reactivation of hepatitis B virus (HBV) during anticancer treatment is a critical issue. When treating patients with solid tumors, it is unclear whether specific cancer types or treatments affect HBV reactivation in hepatitis B surface antigen (HBsAg)-negative and hepatitis B core antibo...
Autores principales: | Sugimoto, Rie, Furukawa, Masayuki, Senju, Takeshi, Aratake, Yoshihusa, Shimokawa, Mototsugu, Tanaka, Yuki, Inada, Hiroki, Noguchi, Tatsuya, Lee, Lingaku, Miki, Masami, Maruyama, Yuji, Hashimoto, Risa, Hisano, Terumasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760444/ https://www.ncbi.nlm.nih.gov/pubmed/33392307 http://dx.doi.org/10.12998/wjcc.v8.i24.6264 |
Ejemplares similares
-
Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer
por: Miki, Masami, et al.
Publicado: (2021) -
Improved indocyanine green retention after short-term lenvatinib withdrawal in three patients with hepatocellular carcinoma
por: Sugimoto, Rie, et al.
Publicado: (2021) -
Serum zinc levels in cancer patients are low and difficult to elevate when complicated by liver cirrhosis: A retrospective study
por: Sugimoto, Rie, et al.
Publicado: (2023) -
Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
por: Miki, Masami, et al.
Publicado: (2022) -
Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis
por: Hayashi, Shiro, et al.
Publicado: (2016)